Further, of the 6 Ph + B‐ALL patients with BCR::ABL1, 2 achieved complete molecular response (BCR::ABL1 negative by quantitative PCR) at the end of initial induction treatment and other 4 achieved it on subsequent treatments. This evidence concerns the gene ABL1 and acute lymphoblastic leukemia.